Investigates molecular factors that drive or suppress tau aggregation, seeding, and neurodegeneration in Alzheimer's disease and related tauopathies.

Uses biochemical assays, cellular and animal models, and human brain tissue to study tau isoforms—including big tau—and identify strategies that may reduce regional vulnerability to tau pathology.